Company

TRINTELLIX® (vortioxetine)

Pharmaceutical Manufacturing And Used Under License by Takeda Pharmaceuticals America 10.00K employees

Employees: 10.00K

www.trintellixhcp.com LinkedIn

TRINTELLIX® (vortioxetine) Overview

Headquarters: And Used Under License by Takeda Pharmaceuticals America
Website: www.trintellixhcp.com
Industry: Pharmaceutical Manufacturing
Employees: 10.00K
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

that don’t relate to the mission or purpose of the page.

About TRINTELLIX® (vortioxetine)

Please see the Full Important Safety Information, including Boxed WARNING regarding Suicidal Thoughts and Behaviors, in the first post below and Full Prescribing Information at: bit.ly/3nel5Jq. WARNING: SUICIDAL THOUGHTS AND BEHAVIORS • Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. • Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors. • TRINTELLIX is not approved for use in pediatric patients. INDICATION TRINTELLIX is indicated for the treatment of Major Depressive Disorder (MDD) in adults. This page is intended for use by U.S. healthcare professionals only. ©2024 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved. 1-877-TAKEDA-7 (1-877-825-3327). US-VOR-1570v1.0 09/24